Effect of Routine Deworming on Weight of Children

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-07

Study Completion Date

2017-06-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Soil Transmitted Helminths (STH) are among the most common infections in the world today. The World Health Organization (WHO) recommends mass administration of deworming medicine as a single routine annual dose to all school age children (SAC)(age 5-16 years) in countries where prevalence of Soil Transmitted Helminthic Infections (STHI) is \> 20% as a safe public health intervention that promotes healthy growth (Category 2 Recommendation). Pakistan is classified as a low burden community with a reported prevalence of STHI \<50%, however,routine deworming is not a policy in Pakistan. Currently, Pakistan is also facing a huge burden of malnutrition in all age groups especially in population belonging to low socioeconomic group. Incidentally, worm infestation by STH also occurs in this group due to associated lack of hygiene and poor living conditions. The coexistence of even moderate STH infections can cause or aggravate malnutrition. The urban slums of Karachi provide environmental, social and behavioral conditions that favor both STH infections and a risk of under nutrition. It is unknown if administering routine dose of deworming medicine to SAC as per WHO recommendation will contribute to improvement in indicators of nutrition status in Pakistani children living in urban slum conditions by eliminating worm infection.Therefore, this study is being conducted to determine the effect of deworming on weight of School Age Children aged between 5 to 16 years.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Relative Efficacy of Two Regimens of Ante-helminthic Treatment

NCT00367627

Helminthiasis

COMPLETED NA

Deworming and Vitamin A (DEVTA) Prepilot Study

NCT00396500

Malnutrition Worm Infestation Under-Fives

COMPLETED PHASE3

Design and Clinical Evaluation of a School Meal With Deworming Properties

NCT02725255

Helminthiasis Tinea Capitis Anemia

COMPLETED PHASE2/PHASE3

Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6

NCT00222547

Village Children

COMPLETED PHASE4

Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children

NCT01658774

Intestinal Helminthiasis Ascariasis Hookworm +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized control trial will be conducted in an urban slum of Karachi. Eligible 5 to 16 year old school age children will be enrolled after parental consent. The calculated total sample size is n= 258. Subjects will be visited at home by researcher and background information, risk factor presence and baseline measurements of weight, Mid Upper Arm Circumference (MUAC) and tricep skinfold thickness (TSF) will be measured. The intervention arm will be administered a single dose of chewable Albendazole 400 mg and the placebo arm will receive 400 mg chewable calcium tablets. The weight, MUAC and TSF will be measured again after 8 weeks to determine the change if any. The selection of locality and allocation of intervention will be done using simple random sampling and computer generated random numbers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Soil Transmitted Helminths

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Albendazole 200 mg 2 tablets single dose

Group Type EXPERIMENTAL

Albendazole

Intervention Type DRUG

Albendazole 400 mg chewable tablets (200 mg each) Two tablets as a single dose recommended as ovicidal, larvicidal and vermicidal against all soil transmitted helminths

Placebo

Calcium 400 mg + vitamin D 2.5 mcg 2 tablets single dose

Group Type PLACEBO_COMPARATOR

Calcium 400 mg + Vitamin D 2.5 mcg

Intervention Type DIETARY_SUPPLEMENT

2 chewable tablets provide recommended daily allowance for calcium and vitamin D

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Albendazole

Albendazole 400 mg chewable tablets (200 mg each) Two tablets as a single dose recommended as ovicidal, larvicidal and vermicidal against all soil transmitted helminths

Intervention Type DRUG

Calcium 400 mg + Vitamin D 2.5 mcg

2 chewable tablets provide recommended daily allowance for calcium and vitamin D

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 5 - 16 years, Healthy, Able to chew/swallow tablets

Exclusion Criteria

* Acutely ill
* Previous deworming dose \< 6 months ago
* Intellectually challenged or physical condition interfering with measurement of primary outcome variables

Minimum Eligible Age

5 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes